A major breakthrough in cancer study is emerging with the use of nanobodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently disabled in many types of malignancies, causing uncontrolled https://extrabookmarking.com/story21949028/nanobodies-revive-tumor-suppressor-p53-a-promising-hope-for-tumor-treatment